Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pierre Fabre reports hypocholesterolemic organosilanes

April 5, 1996

Vitronectin antagonist from Merck & Co. inhibits bone resorption

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

New telomerase inhibitor from Geron

April 5, 1996

Protein kinase C modulators in the pipeline at Procyon

April 5, 1996

PPI-149 selected for development

April 5, 1996

Sparta develops new formulations of taxanes

April 5, 1996

Boehringer Mannheim synthesizes antitumor anthrapyrazoles

April 5, 1996

Sparta to develop new camptothecin formulations

April 5, 1996

PEG-rhSOD advancing in preclinical phase

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...